The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.
Nicholas Ashton, PhD
Advertisement
Senior director of the Fluid Biomarker Program at Banner Health.
Articles by Nicholas Ashton, PhD
The associate professor of neurochemistry at the University of Gothenburg in Sweden talked about a pilot study that explored the potential of finger prick tests to remotely collect blood and provide reliable biomarker results for Alzheimer disease diagnosis. [WATCH TIME: 5 minutes]
Advertisement
Latest Updated Articles
Revolutionizing Alzheimer Disease Diagnosis with Blood Biomarkers: Nicholas Ashton, PhDPublished: July 20th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1
2
sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis
3
NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers
4
Rituximab Displays Long-Term Effectiveness for Relapsing MS
5